PT3558458T - Gliceril 3-hidróxibutiratos para a gestão dos sintomas da enxaqueca - Google Patents

Gliceril 3-hidróxibutiratos para a gestão dos sintomas da enxaqueca

Info

Publication number
PT3558458T
PT3558458T PT178847570T PT17884757T PT3558458T PT 3558458 T PT3558458 T PT 3558458T PT 178847570 T PT178847570 T PT 178847570T PT 17884757 T PT17884757 T PT 17884757T PT 3558458 T PT3558458 T PT 3558458T
Authority
PT
Portugal
Prior art keywords
hydroxybutyrates
glyceryl
symptom management
migraine symptom
migraine
Prior art date
Application number
PT178847570T
Other languages
English (en)
Original Assignee
Neuroenergy Ventures Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuroenergy Ventures Inc filed Critical Neuroenergy Ventures Inc
Publication of PT3558458T publication Critical patent/PT3558458T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT178847570T 2016-12-23 2017-11-30 Gliceril 3-hidróxibutiratos para a gestão dos sintomas da enxaqueca PT3558458T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/389,828 US20180177753A1 (en) 2016-12-23 2016-12-23 Glyceryl 3-hydroxybutyrates for migraine symptom management

Publications (1)

Publication Number Publication Date
PT3558458T true PT3558458T (pt) 2023-11-27

Family

ID=62624821

Family Applications (1)

Application Number Title Priority Date Filing Date
PT178847570T PT3558458T (pt) 2016-12-23 2017-11-30 Gliceril 3-hidróxibutiratos para a gestão dos sintomas da enxaqueca

Country Status (13)

Country Link
US (2) US20180177753A1 (pt)
EP (1) EP3558458B1 (pt)
JP (1) JP7108320B2 (pt)
KR (1) KR102390608B1 (pt)
CN (1) CN110167637B (pt)
BR (1) BR112019012431A2 (pt)
CA (1) CA3046350C (pt)
ES (1) ES2962879T3 (pt)
IL (1) IL267540B (pt)
MX (1) MX2019006844A (pt)
MY (1) MY190308A (pt)
PT (1) PT3558458T (pt)
WO (1) WO2018118369A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
CA3046415A1 (en) 2016-12-21 2018-06-28 Universitats-Kinderspital Beider Basel Migraine prevention and treatment
US10376528B2 (en) 2017-03-10 2019-08-13 Tecton Group, Llc Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor
GB201715654D0 (en) 2017-09-27 2017-11-08 Tdeltas Ltd Method of treatment
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
WO2020147978A1 (de) * 2019-01-17 2020-07-23 Ioi Oleo Gmbh Verfahren zur herstellung von glyceriden von hydroxycarbonsäuren
US20230150914A1 (en) * 2019-01-17 2023-05-18 Ioi Oleo Gmbh Method for producing lipids comprising structural units based on glycerides of hydroxycarboxylc acids
CN113543652A (zh) * 2019-03-14 2021-10-22 神经活力投资公司 用于酮体化合物的掩味制剂
US20220288006A1 (en) * 2019-05-30 2022-09-15 Neuroenergy Ventures, Inc. Glyceryl tris (beta-hydroxybutyrate) and neuronal transient ischemic attacks
CN114008014B (zh) * 2019-06-12 2024-03-22 凯托利皮克斯治疗有限责任公司 用于生产酰基封端的3-羟基羧酸的多元醇基酯的方法
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
CA3237968A1 (en) 2021-11-12 2023-05-19 Ulrich MAYERHOEFFER Polyol-derived compounds
WO2023094654A1 (en) 2021-11-26 2023-06-01 Arxada Ag Acetoacetate based ketals
WO2024083889A1 (en) 2022-10-18 2024-04-25 Arxada Ag Polyol-derived compounds
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
HUE035852T2 (en) 2006-04-03 2018-05-28 Accera Inc Use of ketogen compounds to treat memory decline
WO2008005818A1 (en) * 2006-06-30 2008-01-10 Stepan Co Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose
JP2012515754A (ja) * 2009-01-24 2012-07-12 ファイトファーム ピーエルシー 神経栄養因子介在疾患の治療
CA2873057C (en) 2011-05-09 2020-02-25 University Of South Florida The use of ketone esters for prevention of cns oxygen toxicity
US20140072654A1 (en) 2011-12-23 2014-03-13 Savind, Inc. Cancer with metabolic therapy and hyperbaric oxygen
FR2997302B1 (fr) * 2012-10-29 2015-02-06 Assist Publ Hopitaux De Paris Prevention et traitement des deficits en pyruvate deshydrogenase
WO2014071389A1 (en) 2012-11-05 2014-05-08 Veech Richard L Ketone bodies to protect tissues from damage by ionizing radiation
WO2014085652A1 (en) 2012-11-28 2014-06-05 University Of South Florida Targeting cancer with metabolic therapy and hyperbaric oxygen
PE20151949A1 (es) * 2013-03-19 2016-01-05 Univ South Florida Composiciones y metodos para producir cetosis elevada y sostenida
GB201314127D0 (en) * 2013-08-07 2013-09-18 Tdeltas Ltd Ketone body and ketone body ester for reducing muscle breakdown
EP3549928B1 (en) 2014-01-13 2021-09-22 University of South Florida Methods of sustaining dietary ketosis and its effects on muscle fatigue
US20160078782A1 (en) * 2014-09-17 2016-03-17 The Trustees Of Boston College Glucose Ketone Index for MetabolicTherapy
US9364456B1 (en) 2015-06-30 2016-06-14 University Of South Florida Ketone esters for treatment of angelman syndrome
WO2017011294A1 (en) 2015-07-10 2017-01-19 Cognate Nutritionals, Inc. Prophylaxis and mitigation of migraine headaches using medium chain triglycerides, ketone esters, and other ketogenic sources
US10292952B2 (en) 2016-03-11 2019-05-21 Axcess Global Sciences, Llc Mixed salt compositions for maintaining or restoring electrolyte balance while producing elevated and sustained ketosis
US10376482B2 (en) 2016-04-03 2019-08-13 Franco Cavaleri Butyrate and beta-hydroxybutyrate compositions
CA3021784A1 (en) 2016-04-19 2017-10-26 Keto Patent Group, Inc. Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
WO2018009208A1 (en) 2016-07-08 2018-01-11 Cognate Nutritionals, Inc. Nutritional mitiggation of the cns effects of traumatic brain injury
US20210290581A1 (en) 2016-09-12 2021-09-23 University Of South Florida Neuroregeneration improved by ketone
CA3046415A1 (en) 2016-12-21 2018-06-28 Universitats-Kinderspital Beider Basel Migraine prevention and treatment

Also Published As

Publication number Publication date
WO2018118369A1 (en) 2018-06-28
CN110167637A (zh) 2019-08-23
IL267540B (en) 2022-07-01
CA3046350A1 (en) 2018-06-28
IL267540A (en) 2019-08-29
MX2019006844A (es) 2019-08-16
US20180177753A1 (en) 2018-06-28
JP7108320B2 (ja) 2022-07-28
ES2962879T3 (es) 2024-03-21
MY190308A (en) 2022-04-13
CN110167637B (zh) 2023-03-14
US20190117612A1 (en) 2019-04-25
KR102390608B1 (ko) 2022-04-25
CA3046350C (en) 2022-08-16
EP3558458B1 (en) 2023-10-18
US10792269B2 (en) 2020-10-06
EP3558458A1 (en) 2019-10-30
JP2020502250A (ja) 2020-01-23
EP3558458A4 (en) 2020-08-12
BR112019012431A2 (pt) 2020-04-14
KR20190099465A (ko) 2019-08-27

Similar Documents

Publication Publication Date Title
IL267540A (en) Glyceryl 3-hydroxybutyrates for managing migraine symptoms
HK1231399A1 (zh) 抗性痤瘡的治療
HK1223343A1 (zh) 種馬蹄型鎖
GB2512545B (en) Update management
GB201401715D0 (en) Exfoliation
GB201415067D0 (en) Authentication management
GB2536200B (en) Memory management
GB2536880B (en) Memory management
GB2537960B (en) Memory management
GB201620954D0 (en) Memory management
GB201820012D0 (en) Stock monitoring
GB2529906B (en) Stock Monitoring
AU358772S (en) Stirrup
GB201400853D0 (en) Emergency access bolt
ZA201509306B (en) Inventory management
SG10201501070UA (en) Elevator-group management system
SG11201702458RA (en) Operation management
GB201502124D0 (en) Litter box
GB201403437D0 (en) Easy click box
GB2536199B (en) Memory management
GB201604125D0 (en) Co-crystal
GB2555047B (en) Distribution box
GB2525040B (en) Ear tie
GB201900707D0 (en) Stock monitoring
GB201900708D0 (en) Stock monitoring